chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Hyperhidrosis, Myalgia
Clinical narrative: sweats; chills; muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweats), CHILLS (chills) and MYALGIA (muscle aches) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included BIMATOPROST (LUMIGAN), FLECAINIDE, BISOPROLOL FUMARATE, HYDROCHLOROTHIAZIDE (ZIAC [BISOPROLOL FUMARATE;HYDROCHLOROTHIAZIDE]), ACETYLSALICYLIC ACID (BABY ASPIRIN), ACETAMINOPHEN and BENAZEPRIL HYDROCHLORIDE for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced HYPERHIDROSIS (sweats), CHILLS (chills) and MYALGIA (muscle aches). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 13-Feb-2021, HYPERHIDROSIS (sweats), CHILLS (chills) and MYALGIA (muscle aches) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphonia, Feeling cold, Insomnia
Clinical narrative: Unable to sleep; Body felt cold; Hoarseness; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INSOMNIA (Unable to sleep), FEELING COLD (Body felt cold) and DYSPHONIA (Hoarseness) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 013A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced INSOMNIA (Unable to sleep), FEELING COLD (Body felt cold) and DYSPHONIA (Hoarseness). The patient was treated with PARACETAMOL (TYLENOL) for Feeling cold, at an unspecified dose and frequency. At the time of the report, INSOMNIA (Unable to sleep), FEELING COLD (Body felt cold) and DYSPHONIA (Hoarseness) had not resolved.            Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medications provided.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Gastroenteritis viral, Illness, Pain in extremity
Clinical narrative: Felt really sick; Felt sickness in the stomach; Arm was sore; Fever of 103°F; Chills; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Felt really sick), GASTROENTERITIS VIRAL (Felt sickness in the stomach), PAIN IN EXTREMITY (Arm was sore), PYREXIA (Fever of 103°F) and CHILLS (Chills) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in December 2020. Concomitant products included HYDROCORTISONE, Elasanto, ATORVASTATIN, OMEPRAZOLE, VITAMIN D NOS and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced ILLNESS (Felt really sick), GASTROENTERITIS VIRAL (Felt sickness in the stomach), PAIN IN EXTREMITY (Arm was sore), PYREXIA (Fever of 103°F) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ILLNESS (Felt really sick), GASTROENTERITIS VIRAL (Felt sickness in the stomach), PAIN IN EXTREMITY (Arm was sore), PYREXIA (Fever of 103°F) and CHILLS (Chills) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Mar-2021, Body temperature: 103 (High) Fever of 103 degree F was given..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications included centrum silver vitamins and nasal spray for allergies.   Most recent FOLLOW-UP information incorporated above includes: On 03-Mar-2021: Follow up added patient details, concomitant medications and treatment medications.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Felt really sick; Felt sickness in the stomach; Arm was sore; Fever of 103°F; Chills; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Felt really sick), GASTROENTERITIS VIRAL (Felt sickness in the stomach), PAIN IN EXTREMITY (Arm was sore), PYREXIA (Fever of 103°F) and CHILLS (Chills) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in December 2020. Concomitant products included HYDROCORTISONE, Elasanto, ATORVASTATIN, OMEPRAZOLE, VITAMIN D NOS and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced ILLNESS (Felt really sick), GASTROENTERITIS VIRAL (Felt sickness in the stomach), PAIN IN EXTREMITY (Arm was sore), PYREXIA (Fever of 103°F) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ILLNESS (Felt really sick), GASTROENTERITIS VIRAL (Felt sickness in the stomach), PAIN IN EXTREMITY (Arm was sore), PYREXIA (Fever of 103°F) and CHILLS (Chills) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Mar-2021, Body temperature: 103 (High) Fever of 103 degree F was given..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications included centrum silver vitamins and nasal spray for allergies.   Most recent FOLLOW-UP information incorporated above includes: On 03-Mar-2021: Follow up added patient details, concomitant medications and treatment medications.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: Red area around her arm; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE ERYTHEMA (Red area around her arm) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red area around her arm). At the time of the report, VACCINATION SITE ERYTHEMA (Red area around her arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided. No treatment information provided.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling of body temperature change, Nausea, Pain in extremity
Clinical narrative: arm hurt; hot and cold feeling; nauseous; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 03-Mar-2021 and was forwarded to Moderna on 03-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm hurt), FEELING OF BODY TEMPERATURE CHANGE (hot and cold feeling) and NAUSEA (nauseous) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0412L0A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm hurt), FEELING OF BODY TEMPERATURE CHANGE (hot and cold feeling) and NAUSEA (nauseous). At the time of the report, PAIN IN EXTREMITY (arm hurt), FEELING OF BODY TEMPERATURE CHANGE (hot and cold feeling) and NAUSEA (nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Hyperhidrosis, Pyrexia, Tinnitus, Vaccination complication, Vertigo
Clinical narrative: Ringing in ears; sweating; I could not move out of my bed; fever; Vertigo; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo), TINNITUS (Ringing in ears), HYPERHIDROSIS (sweating), VACCINATION COMPLICATION (I could not move out of my bed) and PYREXIA (fever) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced VERTIGO (Vertigo). On an unknown date, the patient experienced TINNITUS (Ringing in ears), HYPERHIDROSIS (sweating), VACCINATION COMPLICATION (I could not move out of my bed) and PYREXIA (fever). At the time of the report, VERTIGO (Vertigo) had not resolved and TINNITUS (Ringing in ears), HYPERHIDROSIS (sweating), VACCINATION COMPLICATION (I could not move out of my bed) and PYREXIA (fever) outcome was unknown.            No concomitant medications were provided.  Treatment medications were not provided.   This case was linked to MOD-2021-003198 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: New events were added.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Eye pain, Head discomfort, Headache, Pain, Pain in extremity
Clinical narrative: body ache; feel like head was going to blow up; eye were hurting; fingers felt like I had electricity was pounding through my fingertips; intense headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body ache), HEAD DISCOMFORT (feel like head was going to blow up), EYE PAIN (eye were hurting), PAIN IN EXTREMITY (fingers felt like I had electricity was pounding through my fingertips) and HEADACHE (intense headache) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011M20A and 013L20A) for an unknown indication.     The patient's past medical history included COVID-19. Concomitant products included LOSARTAN, POTASSIUM, ESOMEPRAZOLE SODIUM (NEXIUM [ESOMEPRAZOLE SODIUM]), HYDROCHLOROTHIAZIDE and ATORVASTATIN for an unknown indication.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Feb-2021, the patient experienced HEADACHE (intense headache). On an unknown date, the patient experienced PAIN (body ache), HEAD DISCOMFORT (feel like head was going to blow up), EYE PAIN (eye were hurting) and PAIN IN EXTREMITY (fingers felt like I had electricity was pounding through my fingertips). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (body ache), HEAD DISCOMFORT (feel like head was going to blow up), EYE PAIN (eye were hurting), PAIN IN EXTREMITY (fingers felt like I had electricity was pounding through my fingertips) and HEADACHE (intense headache) outcome was unknown.            patient take Oregon Probiotic, Losartan 50mg, Potassium, Nexium, Hydrochlorothiazide 12.5mg, Calcium plus vitamin D3, Atorvastatin, Benadryl at night and Flonase nasal spray as a Concomitant medication.   This case was linked .
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Chills, Fatigue
Clinical narrative: back pain; CHILLS; TIREDNESS; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (back pain), CHILLS (CHILLS) and FATIGUE (TIREDNESS) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, the patient experienced BACK PAIN (back pain), CHILLS (CHILLS) and FATIGUE (TIREDNESS). At the time of the report, BACK PAIN (back pain), CHILLS (CHILLS) and FATIGUE (TIREDNESS) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Dry mouth, Headache, Myalgia
Clinical narrative: Pain; Dry mouth; Chills; Body aches; Headache; fever was 103F; Feeling a bit nauseated; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain), DRY MOUTH (Dry mouth), CHILLS (Chills), MYALGIA (Body aches) and HEADACHE (Headache) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN/HCTZ), ESOMEPRAZOLE SODIUM (NEXIUM [ESOMEPRAZOLE SODIUM]), ATENOLOL, PRAVASTATIN and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced PAIN (Pain), DRY MOUTH (Dry mouth), CHILLS (Chills), MYALGIA (Body aches), HEADACHE (Headache), PYREXIA (fever was 103F) and NAUSEA (Feeling a bit nauseated). At the time of the report, PAIN (Pain), DRY MOUTH (Dry mouth), CHILLS (Chills), MYALGIA (Body aches), HEADACHE (Headache), PYREXIA (fever was 103F) and NAUSEA (Feeling a bit nauseated) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Feb-2021, Body temperature: 103 (High) 103.         On an unknown date, patient's temperature was reported as 99.3.  No corrective treatment was provided.   Most recent FOLLOW-UP information incorporated above includes: On 12-Feb-2021: Added vaccine's dosage detailsand patient's lab data.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Pyrexia
Clinical narrative: Pain; Dry mouth; Chills; Body aches; Headache; fever was 103F; Feeling a bit nauseated; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain), DRY MOUTH (Dry mouth), CHILLS (Chills), MYALGIA (Body aches) and HEADACHE (Headache) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN/HCTZ), ESOMEPRAZOLE SODIUM (NEXIUM [ESOMEPRAZOLE SODIUM]), ATENOLOL, PRAVASTATIN and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced PAIN (Pain), DRY MOUTH (Dry mouth), CHILLS (Chills), MYALGIA (Body aches), HEADACHE (Headache), PYREXIA (fever was 103F) and NAUSEA (Feeling a bit nauseated). At the time of the report, PAIN (Pain), DRY MOUTH (Dry mouth), CHILLS (Chills), MYALGIA (Body aches), HEADACHE (Headache), PYREXIA (fever was 103F) and NAUSEA (Feeling a bit nauseated) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Feb-2021, Body temperature: 103 (High) 103.         On an unknown date, patient's temperature was reported as 99.3.  No corrective treatment was provided.   Most recent FOLLOW-UP information incorporated above includes: On 12-Feb-2021: Added vaccine's dosage detailsand patient's lab data.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Blister, Erythema, Feeling hot, Pain, Pain of skin
Clinical narrative: felt hot after shot; inside left leg had water blisters; eight sites with welts; very red; in much pain on left side; skin is tight; skin hurts; This spontaneous case was reported by a patient and describes the occurrence of FEELING HOT (felt hot after shot), BLISTER (inside left leg had water blisters), URTICARIA (eight sites with welts), ERYTHEMA (very red) and PAIN (in much pain on left side) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING HOT (felt hot after shot), BLISTER (inside left leg had water blisters), URTICARIA (eight sites with welts), ERYTHEMA (very red), PAIN (in much pain on left side), SKIN TIGHTNESS (skin is tight) and PAIN OF SKIN (skin hurts). At the time of the report, FEELING HOT (felt hot after shot), BLISTER (inside left leg had water blisters), URTICARIA (eight sites with welts), ERYTHEMA (very red), PAIN (in much pain on left side), SKIN TIGHTNESS (skin is tight) and PAIN OF SKIN (skin hurts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Skin tightness, Urticaria
Clinical narrative: felt hot after shot; inside left leg had water blisters; eight sites with welts; very red; in much pain on left side; skin is tight; skin hurts; This spontaneous case was reported by a patient and describes the occurrence of FEELING HOT (felt hot after shot), BLISTER (inside left leg had water blisters), URTICARIA (eight sites with welts), ERYTHEMA (very red) and PAIN (in much pain on left side) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING HOT (felt hot after shot), BLISTER (inside left leg had water blisters), URTICARIA (eight sites with welts), ERYTHEMA (very red), PAIN (in much pain on left side), SKIN TIGHTNESS (skin is tight) and PAIN OF SKIN (skin hurts). At the time of the report, FEELING HOT (felt hot after shot), BLISTER (inside left leg had water blisters), URTICARIA (eight sites with welts), ERYTHEMA (very red), PAIN (in much pain on left side), SKIN TIGHTNESS (skin is tight) and PAIN OF SKIN (skin hurts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Cyst
Clinical narrative: Sebaceous cyst that grew in the glands next to the armpit; This spontaneous case was reported by a consumer and describes the occurrence of CYST (Sebaceous cyst that grew in the glands next to the armpit) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced CYST (Sebaceous cyst that grew in the glands next to the armpit). At the time of the report, CYST (Sebaceous cyst that grew in the glands next to the armpit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment for the event include shot of steroids.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Breast pain, Fatigue, Headache, Pain in extremity
Clinical narrative: slight headache on the back of their neck; pain came down the left side of their breast; left arm was a little sore; tired; This spontaneous case was reported by a consumer and describes the occurrence of BREAST PAIN (pain came down the left side of their breast), PAIN IN EXTREMITY (left arm was a little sore), FATIGUE (tired) and HEADACHE (slight headache on the back of their neck) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced BREAST PAIN (pain came down the left side of their breast), PAIN IN EXTREMITY (left arm was a little sore) and FATIGUE (tired). On 05-Feb-2021, the patient experienced HEADACHE (slight headache on the back of their neck). At the time of the report, BREAST PAIN (pain came down the left side of their breast), PAIN IN EXTREMITY (left arm was a little sore) and FATIGUE (tired) had not resolved and HEADACHE (slight headache on the back of their neck) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Allergy to vaccine, Myalgia, Paraesthesia
Clinical narrative: Allergic reaction; felt tingling in face and throat; Soreness in the right armd; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Soreness in the right armd), ALLERGY TO VACCINE (Allergic reaction) and PARAESTHESIA (felt tingling in face and throat) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M020A) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy and Allergy to plants.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced MYALGIA (Soreness in the right armd). On 16-Feb-2021, the patient experienced ALLERGY TO VACCINE (Allergic reaction) and PARAESTHESIA (felt tingling in face and throat). On 16-Feb-2021, MYALGIA (Soreness in the right armd) had resolved. At the time of the report, ALLERGY TO VACCINE (Allergic reaction) and PARAESTHESIA (felt tingling in face and throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Hot flush
Clinical narrative: a minute or two after receiving the vaccine felt a Hot flush feeling and a metallic taste on the; and a metallic taste on the mouth; This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH (a minute or two after receiving the vaccine felt a Hot flush feeling and a metallic taste on the) and DYSGEUSIA (and a metallic taste on the mouth) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. can't read it) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ATORVASTATIN, ESCITALOPRAM OXALATE (LEXAPRO), METOPROLOL, PANTOPRAZOLE, TOPIRAMATE, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), LIRAGLUTIDE (VICTOZA) and ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D) for an unknown indication.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced HOT FLUSH (a minute or two after receiving the vaccine felt a Hot flush feeling and a metallic taste on the) and DYSGEUSIA (and a metallic taste on the mouth). On 01-Mar-2021, HOT FLUSH (a minute or two after receiving the vaccine felt a Hot flush feeling and a metallic taste on the) and DYSGEUSIA (and a metallic taste on the mouth) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        No treatment medications provided by the reporter.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chills, Cognitive disorder, Dizziness, Erythema
Clinical narrative: Her arm swollen; Arm red; Body aches; Chills; Fever of 102.5; Headache for 3 days; Dizzy; Incognitive; Upset stomach; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), COGNITIVE DISORDER (Incognitive), ABDOMINAL DISCOMFORT (Upset stomach), PERIPHERAL SWELLING (Her arm swollen) and ERYTHEMA (Arm red) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028l20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included SPIRONOLACTONE and GABAPENTIN for an unknown indication.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced DIZZINESS (Dizzy), COGNITIVE DISORDER (Incognitive), ABDOMINAL DISCOMFORT (Upset stomach), ERYTHEMA (Arm red), PAIN (Body aches), CHILLS (Chills), PYREXIA (Fever of 102.5) and HEADACHE (Headache for 3 days). On an unknown date, the patient experienced PERIPHERAL SWELLING (Her arm swollen). At the time of the report, DIZZINESS (Dizzy), COGNITIVE DISORDER (Incognitive), ABDOMINAL DISCOMFORT (Upset stomach), PERIPHERAL SWELLING (Her arm swollen), ERYTHEMA (Arm red), PAIN (Body aches), CHILLS (Chills), PYREXIA (Fever of 102.5) and HEADACHE (Headache for 3 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment information provided
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain, Peripheral swelling, Pyrexia
Clinical narrative: Her arm swollen; Arm red; Body aches; Chills; Fever of 102.5; Headache for 3 days; Dizzy; Incognitive; Upset stomach; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), COGNITIVE DISORDER (Incognitive), ABDOMINAL DISCOMFORT (Upset stomach), PERIPHERAL SWELLING (Her arm swollen) and ERYTHEMA (Arm red) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028l20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included SPIRONOLACTONE and GABAPENTIN for an unknown indication.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced DIZZINESS (Dizzy), COGNITIVE DISORDER (Incognitive), ABDOMINAL DISCOMFORT (Upset stomach), ERYTHEMA (Arm red), PAIN (Body aches), CHILLS (Chills), PYREXIA (Fever of 102.5) and HEADACHE (Headache for 3 days). On an unknown date, the patient experienced PERIPHERAL SWELLING (Her arm swollen). At the time of the report, DIZZINESS (Dizzy), COGNITIVE DISORDER (Incognitive), ABDOMINAL DISCOMFORT (Upset stomach), PERIPHERAL SWELLING (Her arm swollen), ERYTHEMA (Arm red), PAIN (Body aches), CHILLS (Chills), PYREXIA (Fever of 102.5) and HEADACHE (Headache for 3 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment information provided
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Constipation
Clinical narrative: constipation; This spontaneous case was reported by a consumer and describes the occurrence of CONSTIPATION (constipation) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder and Anxiety. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) and VITAMIN D NOS for an unknown indication.   On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced CONSTIPATION (constipation). At the time of the report, CONSTIPATION (constipation) had not resolved.            Patient take Thyroid Medication, Antihyperlipidemic Medication, Anti-Anxiety Medication Baby Aspirin and  Vitamin-D as a Concomitant medication.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Product dose omission issue
Clinical narrative: outside recommended dosing interval; mild nausea; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (outside recommended dosing interval) and NAUSEA (mild nausea) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 14-Jan-2021, the patient experienced NAUSEA (mild nausea). On 03-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (outside recommended dosing interval). On 15-Jan-2021, NAUSEA (mild nausea) had resolved. At the time of the report, PRODUCT DOSE OMISSION ISSUE (outside recommended dosing interval) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  Treament information was not provided.   This case was linked to MOD-2021-092081 (Patient Link).
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Pain at the injection site; Itchiness at the injection site; Painful rash on the arm of injection and traveled to chest; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Painful rash on the arm of injection and traveled to chest), VACCINATION SITE PAIN (Pain at the injection site) and VACCINATION SITE PRURITUS (Itchiness at the injection site) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 and COVID-19 virus test on 20-Dec-2020.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced VACCINATION SITE PAIN (Pain at the injection site) and VACCINATION SITE PRURITUS (Itchiness at the injection site). In January 2021, the patient experienced RASH (Painful rash on the arm of injection and traveled to chest). At the time of the report, RASH (Painful rash on the arm of injection and traveled to chest) had not resolved and VACCINATION SITE PAIN (Pain at the injection site) and VACCINATION SITE PRURITUS (Itchiness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment for the events included diphenhydramine.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: DIARRHEA; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (DIARRHEA) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     Concomitant products included CARVEDILOL, TORSEMIDE, DIGOXIN, WARFARIN, OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC), DIAZEPAM, ACETAMINOPHEN, TAMSULOSIN and VITAMINS NOS for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced DIARRHOEA (DIARRHEA). At the time of the report, DIARRHOEA (DIARRHEA) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient was not treated for the reported adverse event.   Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: Non-significant follow up as reporter states in email that its too much work and make it easier. No events mentioned in mail
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain
Clinical narrative: Back pain; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back pain) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history reported.  Concomitant products included CALCIUM and MINERALS NOS, VITAMINS NOS (CENTRUM A TO ZINC) for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BACK PAIN (Back pain). At the time of the report, BACK PAIN (Back pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Pain in extremity
Clinical narrative: soreness on her arm; felt like she had a bruise; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness on her arm) and CONTUSION (felt like she had a bruise) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (soreness on her arm) and CONTUSION (felt like she had a bruise). At the time of the report, PAIN IN EXTREMITY (soreness on her arm) and CONTUSION (felt like she had a bruise) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant information were not provided by the reporter. Treatment information were not provided by the reporter.
Age: 57.0
Sex: U
Vaccine: COVID19
Symptoms: Dyspepsia, Nausea, Vaccination site pain
Clinical narrative: digestion problem; Sore pain at injection site (Right); nausea; This spontaneous case was reported by a consumer and describes the occurrence of DYSPEPSIA (digestion problem), VACCINATION SITE PAIN (Sore pain at injection site (Right)) and NAUSEA (nausea) in a 57-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     The patient's past medical history included Digestion impaired. Concomitant products included PANTOPRAZOLE for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced DYSPEPSIA (digestion problem), VACCINATION SITE PAIN (Sore pain at injection site (Right)) and NAUSEA (nausea). On 02-Mar-2021, VACCINATION SITE PAIN (Sore pain at injection site (Right)) outcome was unknown. At the time of the report, DYSPEPSIA (digestion problem) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Pruritus, Tremor
Clinical narrative: chest was shaking; chest was really tight; itching on my shoulder; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching on my shoulder), TREMOR (chest was shaking) and CHEST DISCOMFORT (chest was really tight) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included APIXABAN (ELIQUIS), LOSARTAN, LEVOTHYROXINE, VITAMIN D NOS and VITAMIN C [ASCORBIC ACID] for an unknown indication.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced PRURITUS (itching on my shoulder). On 24-Feb-2021, the patient experienced TREMOR (chest was shaking) and CHEST DISCOMFORT (chest was really tight). On 24-Feb-2021, TREMOR (chest was shaking) and CHEST DISCOMFORT (chest was really tight) had resolved. At the time of the report, PRURITUS (itching on my shoulder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details included None. Concomitant medication also included Ocuvite .   Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: Follow up contains non-significant information. Reporter Fax number obtained.
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: itchy; Arm is red; swollen arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (Arm is red) and VACCINATION SITE SWELLING (swollen arm) in a 93-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 05-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (Arm is red) and VACCINATION SITE SWELLING (swollen arm). At the time of the report, VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (Arm is red) and VACCINATION SITE SWELLING (swollen arm) outcome was unknown.            No concomitant medication was mentioned. No treatment medication was mentioned.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus
Clinical narrative: redness; itching; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness) and PRURITUS (itching) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (redness) and PRURITUS (itching). At the time of the report, ERYTHEMA (redness) and PRURITUS (itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications details were not reported by the reporter. No treatment information was provided.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: itchiness; rash; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchiness) and RASH (rash) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (itchiness) and RASH (rash). At the time of the report, PRURITUS (itchiness) and RASH (rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Sex: F
Vaccine: COVID19
Symptoms: Haematoma, Influenza like illness, Injection site erythema, Lymphadenopathy, Pyrexia
Clinical narrative: flu-like symptoms; maybe hematoma; warm to the touch; lymph nodes were swollen in left armpit; has a fever; soreness was till there; real red/ redness; swollen; 2.5 by 2.5 inches mass; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms), HAEMATOMA (maybe hematoma), VACCINATION SITE WARMTH (warm to the touch), INJECTION SITE ERYTHEMA (real red/ redness) and VACCINATION SITE SWELLING (swollen) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (real red/ redness), VACCINATION SITE SWELLING (swollen), VACCINATION SITE SWELLING (2.5 by 2.5 inches mass) and VACCINATION SITE PAIN (soreness was till there). On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms), HAEMATOMA (maybe hematoma), VACCINATION SITE WARMTH (warm to the touch), LYMPHADENOPATHY (lymph nodes were swollen in left armpit) and PYREXIA (has a fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and TROLAMINE SALICYLATE (ASPERCREME [TROLAMINE SALICYLATE]) at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms), VACCINATION SITE WARMTH (warm to the touch), VACCINATION SITE SWELLING (swollen) and LYMPHADENOPATHY (lymph nodes were swollen in left armpit) had not resolved, HAEMATOMA (maybe hematoma) and PYREXIA (has a fever) outcome was unknown, INJECTION SITE ERYTHEMA (real red/ redness) and VACCINATION SITE PAIN (soreness was till there) had resolved and VACCINATION SITE SWELLING (2.5 by 2.5 inches mass) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling, Vaccination site warmth
Clinical narrative: flu-like symptoms; maybe hematoma; warm to the touch; lymph nodes were swollen in left armpit; has a fever; soreness was till there; real red/ redness; swollen; 2.5 by 2.5 inches mass; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms), HAEMATOMA (maybe hematoma), VACCINATION SITE WARMTH (warm to the touch), INJECTION SITE ERYTHEMA (real red/ redness) and VACCINATION SITE SWELLING (swollen) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (real red/ redness), VACCINATION SITE SWELLING (swollen), VACCINATION SITE SWELLING (2.5 by 2.5 inches mass) and VACCINATION SITE PAIN (soreness was till there). On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms), HAEMATOMA (maybe hematoma), VACCINATION SITE WARMTH (warm to the touch), LYMPHADENOPATHY (lymph nodes were swollen in left armpit) and PYREXIA (has a fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and TROLAMINE SALICYLATE (ASPERCREME [TROLAMINE SALICYLATE]) at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms), VACCINATION SITE WARMTH (warm to the touch), VACCINATION SITE SWELLING (swollen) and LYMPHADENOPATHY (lymph nodes were swollen in left armpit) had not resolved, HAEMATOMA (maybe hematoma) and PYREXIA (has a fever) outcome was unknown, INJECTION SITE ERYTHEMA (real red/ redness) and VACCINATION SITE PAIN (soreness was till there) had resolved and VACCINATION SITE SWELLING (2.5 by 2.5 inches mass) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache). At the time of the report, HEADACHE (headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.